TI
XLRN

Turner Investments’s Acceleron Pharma XLRN Stock Holding History

Turner Investments’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-57,240
Closed -$1.43M – 284
2015
Q3 		$1.43M Sell
57,240
-500
-0.9% -$15K 0.29% 108
2015
Q2 		$1.83M Buy
+57,740
New +$1.86M 0.33% 103

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Turner Investments's XLRN Position: Q4 2015 in Review

Turner Investments sold out of Acceleron Pharma (XLRN) in Q4 2015, closing a stake of 57,240 shares — an estimated $1.43M sold.

Turner Investments first reported a position in XLRN in Q2 2015 and held it in 2 quarters. The position peaked at $1.83M in Q2 2015. 125 funds tracked by Wall St. Rank hold XLRN as of Q4 2015.

  • Turner Investments reported no remaining Acceleron Pharma position as of Q4 2015 after selling out during the quarter.
  • Turner Investments sold 57,240 Acceleron Pharma shares in Q4 2015, an estimated $1.43M.
  • Turner Investments first reported a position in Acceleron Pharma in Q2 2015 and held it in 2 quarters.
  • Turner Investments's Acceleron Pharma position peaked at $1.83M in Q2 2015.
  • 125 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2015.

Based on Turner Investments's 13F filing for Q4 2015, filed 9 Feb 2016.